AAAAAA

   
Results: 1-17 |
Results: 17
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL
Authors: DAWSON N FIGG WD BRAWLEY OW BERGAN R COOPER MR SENDEROWICZ A HEADLEE D STEINBERG SM SUTHERLAND M PATRONAS N SAUSVILLE E LINEHAN WM REED E SARTOR O
Citation: N. Dawson et al., PHASE-II STUDY OF SURAMIN PLUS AMINOGLUTETHIMIDE IN 2 COHORTS OF PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER - SIMULTANEOUS ANTIANDROGEN WITHDRAWAL AND PRIOR ANTIANDROGEN WITHDRAWAL, Clinical cancer research, 4(1), 1998, pp. 37-44
TUBULIN CONTENT AND BETA-TUBULIN ISOTYPE DISTRIBUTION OF CELL-LINES USED IN THE NCI IN-VITRO DRUG SCREEN
Authors: BAI R VERDIERPINARD P LUDUENA RF BANERJEE A SAUSVILLE E HAMEL E
Citation: R. Bai et al., TUBULIN CONTENT AND BETA-TUBULIN ISOTYPE DISTRIBUTION OF CELL-LINES USED IN THE NCI IN-VITRO DRUG SCREEN, Molecular biology of the cell, 9, 1998, pp. 877-877
FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53
Authors: BYRD JC SHINN C WASELENKO JK FUCHS EJ LEHMAN TA NGUYEN PL FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53, Blood, 92(10), 1998, pp. 3804-3816
THE AMINO-TERMINAL DOMAIN OF HEAT-SHOCK-PROTEIN-90 (HSP90) THAT BINDSGELDANAMYCIN IS AN ATP ADP SWITCH DOMAIN THAT REGULATES HSP90 CONFORMATION/
Authors: GRENERT JP SULLIVAN WP FADDEN P HAYSTEAD TAJ CLARK J MIMNAUGH E KRUTZSCH H OCHEL HJ SCHULTE TW SAUSVILLE E NECKERS LM TOFT DO
Citation: Jp. Grenert et al., THE AMINO-TERMINAL DOMAIN OF HEAT-SHOCK-PROTEIN-90 (HSP90) THAT BINDSGELDANAMYCIN IS AN ATP ADP SWITCH DOMAIN THAT REGULATES HSP90 CONFORMATION/, The Journal of biological chemistry, 272(38), 1997, pp. 23843-23850
FLAVOPIRIDOL (NSC649890) PHARMACOKINETICS SUGGEST ENTEROHEPATIC CIRCULATION
Authors: LUSH RM STINSON S SENDEROWICZ AM HILL K FEUER J HEADLEE D FIGG W SAUSVILLE E
Citation: Rm. Lush et al., FLAVOPIRIDOL (NSC649890) PHARMACOKINETICS SUGGEST ENTEROHEPATIC CIRCULATION, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 34-34
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: BYRD JC WASELENKO JK SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS MARKED IN-VITRO ACTIVITY AGAINST BOTH THE K-562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3810-3810
UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS
Authors: SHINN CA BYRD JC WASELENKO JK SAUSVILLE E MILLER C GORE S GREVER MR
Citation: Ca. Shinn et al., UCN-01 HAS SIGNIFICANT IN-VITRO ACTIVITY IN BOTH THE RESISTANT K562 CELL-LINE AND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3848-3848
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS
Authors: WASELENKO JK BYRD JC SHINN CA MILLER C GORE S SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST THE K-562 CELL-LINEAND HUMAN ACUTE-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 3858-3858
UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 4125-4125
CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO
Authors: WASELENKO JK BYRD JC SHINN CA FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO, Blood, 90(10), 1997, pp. 4147-4147
FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS
Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FUCHS E FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 2366-2366
FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL)
Authors: BYRD JC WASELENKO JK SHINN CA BEDI A FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2367-2367
FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION
Authors: WASELENKO JK PRZYGODZKI R GREVER MR SHINN CA SAUSVILLE E BYRD JC
Citation: Jk. Waselenko et al., FLAVOPIRIDOL, UCN-01, FR901228 AND GEMCITABINE HAVE SIGNIFICANT IN-VITRO ACTIVITY IN DE-NOVO B-CELL PROLYMPHOCYTIC LEUKEMIA WITH ABERRANT P53 FUNCTION, Blood, 90(10), 1997, pp. 2369-2369
FLAVOPIRIDOL (L86-8275,NSC-649890), A NEW KINASE INHIBITOR FOR TUMOR-THERAPY
Authors: SEDLACEK HH CZECH J NAIK R KAUR G WORLAND P LOSIEWICZ M PARKER B CARLSON B SMITH A SENDEROWICZ A SAUSVILLE E
Citation: Hh. Sedlacek et al., FLAVOPIRIDOL (L86-8275,NSC-649890), A NEW KINASE INHIBITOR FOR TUMOR-THERAPY, International journal of oncology, 9(6), 1996, pp. 1143-1168
STRUCTURAL BASIS FOR SPECIFICITY AND POTENCY OF A FLAVONOID INHIBITOROF HUMAN CDK2, A CELL-CYCLE KINASE
Authors: DEAZEVEDO WF MUELLERDIECKMANN HJ SCHULZEGAHMEN U WORLAND PJ SAUSVILLE E KIM SH
Citation: Wf. Deazevedo et al., STRUCTURAL BASIS FOR SPECIFICITY AND POTENCY OF A FLAVONOID INHIBITOROF HUMAN CDK2, A CELL-CYCLE KINASE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(7), 1996, pp. 2735-2740
NEUROMEDIN-B RECEPTOR TRANSFECTED BALB 3T3 CELLS - SIGNAL-TRANSDUCTION AND EFFECTS OF ECTOPIC RECEPTOR EXPRESSION ON CELL-GROWTH/
Authors: DOBRZANSKI D SHARONI Y WADA E BATTEY J SAUSVILLE E
Citation: D. Dobrzanski et al., NEUROMEDIN-B RECEPTOR TRANSFECTED BALB 3T3 CELLS - SIGNAL-TRANSDUCTION AND EFFECTS OF ECTOPIC RECEPTOR EXPRESSION ON CELL-GROWTH/, Regulatory peptides, 45(3), 1993, pp. 341-352
Risultati: 1-17 |